Acalculous cholecystitis during the course of acute Epstein–Barr virus infection and Gilbert's syndrome  by Iaria, Chiara et al.
LETTER TO THE EDITOR
International Journal of Infectious Diseases (2009) 13, e519—e520
http://intl.elsevierhealth.com/journals/ijidAcalculous cholecystitis during the course
of acute Epstein—Barr virus infection and
Gilbert’s syndrome
We read with great interest the article by Attilakos et al.
regarding the development of acute acalculous cholecystitis
(AAC) during the course of Epstein—Barr virus (EBV) infection
in two children with Gilbert’s syndrome (GS).1
GS is a benign condition characterized by mild uncon-
jugated hyperbilirubinemia in the absence of liver disease
or overt hemolysis; it occurs in 11—16% of Caucasians. In
Caucasians, all patients with GS appear to be homozygous
for an additional TA in the TATAA box of the UGT1A1
gene promoter, which encodes a uridine diphosphate
glucuronosyltransferase that catalyzes bilirubin glucuroni-
dation.2
We found very interesting the hypothesis that the co-
occurrence of GS may play a role in the pathogenesis of
AAC during the acute EBV infection, and so recalled the case
of an 18-year-old girl who presented one year ago with AAC
during the course of acute EBV infection, which we have
previously described,3 to ascertain if she was a carrier of the
UGT1A1 gene promoter mutation.
Analysis of the A(TA)nTAA motif in the promoter region of
the UTG1A1 gene was performed by PCR using previously
described primers.4 The analysis gave a negative result with
the presence of a normal (TA)6 allele.
The exact mechanisms that are implicated in the patho-
genesis of AAC during the course of acute EBV infection
have not been elucidated, but direct invasion by EBV of
gallbladder epithelium and/or irritation of the gallbladder
from the bile stasis are considered possible causes.
Recently, EBV-induced hepatitis has been recognized as
an important cause of cholestasis. To date, ten cases of
AAC associated with an EBV infection have been reported
and all have occurred in European patients, four of them
from Greece1,3,5—11
The high levels of unconjugated bilirubin and the 30%
increase in bilirubin monoglucuronide (less water soluble
than the normal diglucuronide) excreted in the bile
observed in patients with GS might increase the cholestasis
induced by EBV infection. However, this was not the case in
our patient.
We think that if the hypothesis of Attilakos et al. were
true, many more cases of AAC would have occurred in1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.01.012patients with GS, and GS would probably already have been
considered a risk factor for cholecystitis independently from
an EBV infection. On the contrary, a MEDLINE search combin-
ing the term ‘Gilbert’ AND ‘cholecystitis’ yields only four
papers and in none of them is an association between GS and
cholecystitis considered.
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